The Project Outcomes section of the Research Performance Progress Report (RPPR) provides information about the cumulative outcomes or findings of the project. This information is made available to the public through NIH RePORTER, so take that into account when completing this section!
As noted in the RPPR Instruction Guide, Project Outcome summaries should not exceed half a page and must be written according to the following guidelines:
- Is written for the general public in clear, concise, and comprehensible language
- Is suitable for dissemination to the general public, as the information may be available electronically
- Does not include proprietary, confidential information or trade secrets
Importantly, recipients conducting NIH-defined Phase III Clinical Trials must also include results of valid analyses by sex/gender, race, and ethnicity in the Project Outcome Summary. For more information on valid analysis, see the Analyses by Sex or Gender, Race and Ethnicity for NIH-defined Phase III Clinical Trials (Valid Analysis) page.
Looking for an example to use as a reference? Check out our Sample Project Outcomes page for examples, including one that addresses the results of valid analysis by sex/gender, race, and ethnicity.